PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-09-12

Date Title Company
12-Sep-2024 KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024 AccessWire
12-Sep-2024 Lash Me NYC Introduces New Reduced Pricing on Select Lash and Brow Services AccessWire
12-Sep-2024 Medsmart Wellness Centers, a Subsidiary of Med Holdings Group Inc., Expands Telemedicine and Announces Strategic Partnerships AccessWire
12-Sep-2024 Beacon Oral Specialists Announces Strategic Partnerships With Oral Surgery Partners and Vero Beach Surgical Arts AccessWire
12-Sep-2024 Sema Slim: A New Safe and Effective Medical Weight Loss Solution Now Available Online AccessWire
12-Sep-2024 CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program AccessWire
12-Sep-2024 Interactive Strength Inc. (Nasdaq: TRNR) Secures Global Vendor Status with Industry Leader RSG Group for CLMBR AccessWire
12-Sep-2024 Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials AccessWire
12-Sep-2024 CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program CureVac
12-Sep-2024 ABPI response to the Darzi Review: innovation must be at the heart of improvement ABPI
12-Sep-2024 Biocomposites to distribute its NanoBone® product range in the UK Biocomposites
12-Sep-2024 Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme Epitopea
12-Sep-2024 KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF Kadans Science Partner
12-Sep-2024 Arctoris acquires Eli Lilly ‘Life Science Studio’ laboratory Arctoris
12-Sep-2024 Vapourtec invests in future with Bristol CDT partnership Vapourtec
12-Sep-2024 QL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024 Beijing QL Biopharmaceutical Co., Ltd
12-Sep-2024 Moderna R&D Day Highlights Progress and Strategic Priorities AccessWire
12-Sep-2024 Birmingham Health Partners Centre for Regulatory Science and Innovation director appointed University of Birmingham
12-Sep-2024 PharmaSGP continues dynamic growth path in the first half of 2024 PharmaSGP Holding SE
12-Sep-2024 PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares PharmaSGP Holding SE